Funding

The group is currently funded by:

COST Action BM1404 Mye-EUNITER which is part of the European Union Framework Program Horizon 2020 (http://www.mye-euniter.eu)

Completed research support:

Wilhelm Sander Foundation (2016-2017): The role of monocytic immune cells for hepatocarcinogenesis and releance of therapeutic modulation of CCR2-dependent invasion and differentiation

START-Programm der Medizinischen Fakultät der RWTH-Aachen (2014-2015)

DFG-supported graduate school „Biointerface“ (2007-2010)